位置:首页 > 蛋白库 > LEPR_PIG
LEPR_PIG
ID   LEPR_PIG                Reviewed;        1165 AA.
AC   O02671; Q95257; Q9MZS2; Q9N1F9; Q9XSN9;
DT   19-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   19-OCT-2002, sequence version 3.
DT   25-MAY-2022, entry version 128.
DE   RecName: Full=Leptin receptor;
DE            Short=LEP-R;
DE   AltName: Full=OB receptor;
DE            Short=OB-R;
DE   AltName: CD_antigen=CD295;
DE   Flags: Precursor;
GN   Name=LEPR; Synonyms=OBR;
OS   Sus scrofa (Pig).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Suina; Suidae; Sus.
OX   NCBI_TaxID=9823;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=10911396;
RX   DOI=10.1002/1098-2795(200008)56:4<465::aid-mrd4>3.0.co;2-q;
RA   Ruiz-Cortes Z.T., Men T., Palin M.-F., Downey B.R., Lacroix D.A.,
RA   Murphy B.D.;
RT   "Porcine leptin receptor: molecular structure and expression in the
RT   ovary.";
RL   Mol. Reprod. Dev. 56:465-474(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-123.
RC   STRAIN=Yorkshire X Meishan;
RA   Lacroix D.A., Gevry N.Y., Ruiz-Cortes Z.T., Murphy B.D.;
RT   "Porcine leptin receptor intron 3, partial.";
RL   Submitted (SEP-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 7-854.
RC   TISSUE=Liver;
RA   Hu X., Dai R., Li N., Wu C.;
RT   "Expression, detection, and partial cloning of porcine leptin receptor
RT   (OBR) gene.";
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 13-159 AND 916-1088.
RC   TISSUE=Hypothalamus;
RA   Matteri R.L., Carroll J.A.;
RT   "Partial cDNA sequence of the porcine leptin receptor.";
RL   Submitted (DEC-1997) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 109-123.
RX   PubMed=9800339;
RA   Stratil A., Kopecny M., Moser G., Schroffel J. Jr., Cepica S.;
RT   "HpaII and RsaI PCR-RFLPs within an intron of the porcine leptin receptor
RT   gene (LEPR) and its linkage mapping.";
RL   Anim. Genet. 29:405-406(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 408-470.
RX   PubMed=9069130; DOI=10.1007/s003359900397;
RA   Ernst C.W., Kapke P.A., Yerle M., Rothschild M.F.;
RT   "The leptin receptor gene (LEPR) maps to porcine chromosome 6.";
RL   Mamm. Genome 8:226-226(1997).
CC   -!- FUNCTION: Receptor for hormone LEP/leptin (By similarity). On ligand
CC       binding, mediates LEP central and peripheral effects through the
CC       activation of different signaling pathways such as JAK2/STAT3 and MAPK
CC       cascade/FOS. In the hypothalamus, LEP acts as an appetite-regulating
CC       factor that induces a decrease in food intake and an increase in energy
CC       consumption by inducing anorexinogenic factors and suppressing
CC       orexigenic neuropeptides, also regulates bone mass and secretion of
CC       hypothalamo-pituitary-adrenal hormones. In the periphery, increases
CC       basal metabolism, influences reproductive function, regulates
CC       pancreatic beta-cell function and insulin secretion, is pro-angiogenic
CC       and affects innate and adaptive immunity (By similarity). Control of
CC       energy homeostasis and melanocortin production (stimulation of POMC and
CC       full repression of AgRP transcription) is mediated by STAT3 signaling,
CC       whereas distinct signals regulate NPY and the control of fertility,
CC       growth and glucose homeostasis. Involved in the regulation of counter-
CC       regulatory response to hypoglycemia by inhibiting neurons of the
CC       parabrachial nucleus. Has a specific effect on T lymphocyte responses,
CC       differentially regulating the proliferation of naive and memory T-
CC       cells. Leptin increases Th1 and suppresses Th2 cytokine production (By
CC       similarity). {ECO:0000250|UniProtKB:P48356,
CC       ECO:0000250|UniProtKB:P48357}.
CC   -!- SUBUNIT: Present as a mixture of monomers and dimers. The
CC       phosphorylated receptor binds a number of SH2 domain-containing
CC       proteins such as JAK2, STAT3, PTPN11, and SOCS3 (By similarity).
CC       Interaction with SOCS3 inhibits JAK/STAT signaling and MAPK cascade (By
CC       similarity). {ECO:0000250|UniProtKB:P48356,
CC       ECO:0000250|UniProtKB:P48357}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:P48357};
CC       Single-pass type I membrane protein {ECO:0000250|UniProtKB:P48357}.
CC       Basolateral cell membrane {ECO:0000250|UniProtKB:P48357}.
CC   -!- TISSUE SPECIFICITY: Kidney, liver, spleen, lung, brain, testis, uterus,
CC       ovary, corpus luteum, theca and granulosa cells.
CC   -!- DOMAIN: The cytoplasmic domain may be essential for intracellular
CC       signal transduction by activation of JAK tyrosine kinase and STATs.
CC   -!- DOMAIN: The WSXWS motif appears to be necessary for proper protein
CC       folding and thereby efficient intracellular transport and cell-surface
CC       receptor binding.
CC   -!- DOMAIN: The box 1 motif is required for JAK interaction and/or
CC       activation.
CC   -!- PTM: On ligand binding, phosphorylated on two conserved C-terminal
CC       tyrosine residues by JAK2. Tyr-986 is required for complete binding and
CC       activation of PTPN11, ERK/FOS activation,for interaction with SOCS3 and
CC       SOCS3 mediated inhibition of leptin signaling. Phosphorylation on Tyr-
CC       1141 is required for STAT3 binding/activation. Phosphorylation of Tyr-
CC       1079 has a more accessory role. {ECO:0000250|UniProtKB:P48356}.
CC   -!- SIMILARITY: Belongs to the type I cytokine receptor family. Type 2
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF092422; AAC61766.1; -; mRNA.
DR   EMBL; AH009271; AAF66822.1; -; Genomic_DNA.
DR   EMBL; AF167719; AAF89633.1; -; mRNA.
DR   EMBL; AF036908; AAB88825.1; -; mRNA.
DR   EMBL; U67739; AAB07892.1; -; mRNA.
DR   EMBL; AJ223162; CAA11142.1; -; Genomic_DNA.
DR   EMBL; AJ223163; CAA11143.1; -; Genomic_DNA.
DR   EMBL; U72070; AAC48707.1; -; Genomic_DNA.
DR   RefSeq; NP_001019758.1; NM_001024587.1.
DR   AlphaFoldDB; O02671; -.
DR   SMR; O02671; -.
DR   STRING; 9823.ENSSSCP00000022838; -.
DR   PaxDb; O02671; -.
DR   PRIDE; O02671; -.
DR   GeneID; 396836; -.
DR   KEGG; ssc:396836; -.
DR   CTD; 3953; -.
DR   eggNOG; ENOG502RK5B; Eukaryota.
DR   InParanoid; O02671; -.
DR   Proteomes; UP000008227; Unplaced.
DR   Proteomes; UP000314985; Unplaced.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043235; C:receptor complex; IBA:GO_Central.
DR   GO; GO:0019955; F:cytokine binding; IBA:GO_Central.
DR   GO; GO:0004896; F:cytokine receptor activity; IBA:GO_Central.
DR   GO; GO:0038021; F:leptin receptor activity; ISS:UniProtKB.
DR   GO; GO:0017046; F:peptide hormone binding; IBA:GO_Central.
DR   GO; GO:0001525; P:angiogenesis; ISS:UniProtKB.
DR   GO; GO:0098868; P:bone growth; ISS:UniProtKB.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0097009; P:energy homeostasis; ISS:UniProtKB.
DR   GO; GO:0042593; P:glucose homeostasis; ISS:UniProtKB.
DR   GO; GO:0033210; P:leptin-mediated signaling pathway; ISS:UniProtKB.
DR   GO; GO:0010507; P:negative regulation of autophagy; ISS:UniProtKB.
DR   GO; GO:0006909; P:phagocytosis; ISS:UniProtKB.
DR   GO; GO:0046850; P:regulation of bone remodeling; ISS:UniProtKB.
DR   GO; GO:0060259; P:regulation of feeding behavior; ISS:UniProtKB.
DR   GO; GO:0044321; P:response to leptin; ISS:UniProtKB.
DR   GO; GO:0019953; P:sexual reproduction; ISS:UniProtKB.
DR   GO; GO:0030217; P:T cell differentiation; ISS:UniProtKB.
DR   CDD; cd00063; FN3; 1.
DR   Gene3D; 2.60.40.10; -; 7.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR003529; Hematopoietin_rcpt_Gp130_CS.
DR   InterPro; IPR003531; Hempt_rcpt_S_F1_CS.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR010457; IgC2-like_lig-bd.
DR   InterPro; IPR041182; LEP-R_IGD.
DR   InterPro; IPR015752; Lep_receptor.
DR   PANTHER; PTHR23036:SF109; PTHR23036:SF109; 1.
DR   Pfam; PF06328; Lep_receptor_Ig; 1.
DR   Pfam; PF18589; ObR_Ig; 2.
DR   SMART; SM00060; FN3; 4.
DR   SUPFAM; SSF49265; SSF49265; 4.
DR   PROSITE; PS50853; FN3; 4.
DR   PROSITE; PS01353; HEMATOPO_REC_L_F2; 1.
PE   2: Evidence at transcript level;
KW   Cell membrane; Disulfide bond; Glycoprotein; Membrane; Obesity;
KW   Phosphoprotein; Receptor; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   CHAIN           22..1165
FT                   /note="Leptin receptor"
FT                   /id="PRO_0000010907"
FT   TOPO_DOM        22..838
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        839..861
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        862..1165
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          239..332
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          539..634
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          642..736
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          740..834
FT                   /note="Fibronectin type-III 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   REGION          467..484
FT                   /note="Leptin-binding"
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   REGION          892..897
FT                   /note="Required for JAK2 activation"
FT                   /evidence="ECO:0000250|UniProtKB:P48356"
FT   REGION          897..905
FT                   /note="Required for STAT3 phosphorylation"
FT                   /evidence="ECO:0000250|UniProtKB:P48356"
FT   MOTIF           622..626
FT                   /note="WSXWS motif"
FT   MOTIF           870..878
FT                   /note="Box 1 motif"
FT   MOD_RES         881
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   MOD_RES         986
FT                   /note="Phosphotyrosine; by JAK2"
FT                   /evidence="ECO:0000250|UniProtKB:P48356"
FT   MOD_RES         1079
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P48356"
FT   MOD_RES         1141
FT                   /note="Phosphotyrosine; by JAK2"
FT                   /evidence="ECO:0000250|UniProtKB:P48356"
FT   CARBOHYD        41
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        55
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        72
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        80
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        98
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        187
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        206
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        276
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        347
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        397
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        433
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        624
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        659
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        670
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        697
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        728
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        750
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        37..90
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   DISULFID        89..99
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   DISULFID        131..142
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   DISULFID        186..196
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   DISULFID        188..193
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   DISULFID        352..412
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   DISULFID        413..418
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   DISULFID        436..447
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   DISULFID        473..528
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   DISULFID        488..498
FT                   /evidence="ECO:0000250|UniProtKB:P48357"
FT   CONFLICT        7..9
FT                   /note="SVA -> CVV (in Ref. 3; AAF89633)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        69
FT                   /note="T -> M (in Ref. 3; AAF89633 and 4; AAB07892)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        73
FT                   /note="S -> I (in Ref. 1; AAC61766)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        283
FT                   /note="E -> K (in Ref. 3; AAF89633)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        350
FT                   /note="F -> L (in Ref. 3; AAF89633)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        362
FT                   /note="S -> P (in Ref. 3; AAF89633)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        365
FT                   /note="K -> E (in Ref. 3; AAF89633)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        385
FT                   /note="G -> S (in Ref. 3; AAF89633)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        974
FT                   /note="R -> C (in Ref. 4; AAB88825)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1047
FT                   /note="T -> I (in Ref. 4; AAB88825)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1165 AA;  132523 MW;  9F02EADDEDC26D21 CRC64;
     MTCPKFSVAL LHWEFIYVIT AFDLAYPITP WKFKLSCMPP NTTYDFLLPA GISKNTSTLN
     GHDEAVVETE LNSSGTYLSN LSSKTTFHCC FWSEEDKNCS VHADNIAGKA FVSAVNSLVF
     QQTGANWNIQ CWMKEDLKLF ICYMESLFKN PFKNYDLKVH LLYVLLEVLE GSPLLPQKGS
     FQSVQCNCSA RECCECHVPV SAAKLNYTLL MYLKITSGGA VFHSPLMSVQ PINVVKPDPP
     LGLHMEITDT GNLKISWSSP TLVPFQLQYQ VKYSENSTTN MREADEIVSD TSLLVDSVLP
     GSSYEVQVRG KRLDGPGIWS DWSTPFTFTT QDVIYFPPKI LTSVGSNISF HCIYKNENKI
     VSSKKIVWWM NLAEKIPQSQ YDVVGDHVSK VTFPNMNATK PRGKFTYDAV YCCNEHECHH
     RYAELYVIDV NINISCETDG YLTKMTCRWS TNAIQSLVGS TLQLRYHRSS LYCSDVPSVH
     PISEPKDCQL QRDGFYECIF QPIFLLSGYT MWIRINHPLG SLDSPPTCVI PDSVVKPLPP
     SSVKAEITAK IGLLKISWEK PVFPENNLQF QIRYGLSGKE VQWKIYEVYD TKLKSTSLPV
     PDLCAVYAVQ VRCKRLDGLG YWSNWSTPAY TVVTDVKVPI RGPEFWRIIN EDATKKERNI
     TLLWKPLMKN DSLCSVRSYV VKHHTSRHGT WSEDVGNHTK LTFLWTEQAH SVTVLAVNSI
     GASSANFNLT FSWPMSKVNI VQSLSAYPLN SSCVGLSWLL SPSDYNLMYF ILEWKILNED
     HEIKWLRIPS SVKKYYIHDH FIPIEKYQFS LYPIFMEGVG KPKIINSFTQ DGEKHRNDAG
     LYVIVPIIIS SSILLLGTLL MSHQRMKKLF WEDVPNPKNC SWAQGLNFQK PETFEHLFIK
     HTESVTFGPL LLEPETISED ISVDTSWKNK DEMVPPTTVS LLLTTPDLEK SSICISDQRS
     SAHFSEAESM EITREDENRR QPSIKYATLL SSPKSGETEQ EQELVSSLVS RCFSSSNSLP
     KESFSNSSWE IETQAFFILS DQHPNMTSPH LSFSEGLDEL MKFEGNFPKE HNDERSVYYL
     GVTSIKKRES DVFLTDESRV RCPFPAHCLF ADIKILQESC SHLVENNFNL GTSGQKTFVS
     YMPQFQTCST QTQKIMENKM YDLTV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024